Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL306215 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL15638 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL33380 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL11572945 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL14629852 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL16739381 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL393971 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL476167 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL4290016 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN | |
| Methacrylic Acid SCHEMBL7098371 | 1.00 | TDP1 (0.42) | TDP1TGFBR1FFAR3LCKFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 408 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4121279-B1 | METHOD FOR PRODUCING EMBEDDED OR HYBRID HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-07-10 | — | — | EP | claimed |
| US-20240157322-A1 | CROSSLINKED CORE-SHELL MICROCAPSULES | FIRMENICH SA (CH) | 2024-05-16 | — | — | US | claimed |
| EP-4313393-A1 | CROSSLINKED CORE-SHELL MICROCAPSULES | Firmenich SA (CH) | 2024-02-07 | — | — | EP | claimed |
| US-11833770-B2 | Method for producing embedded or hybrid hydrogel contact lenses | ALCON INC. (CH) | 2023-12-05 | — | — | US | claimed |
| US-11717471-B2 | Hydrogel microcapsules | ISP INVESTMENTS LLC (US) | 2023-08-08 | — | — | US | claimed |
| US-11667820-B2 | Adhesive composition for polarizing plate, polarizing plate, and optical display device | SAMSUNG SDI CO., LTD. (KR) | 2023-06-06 | — | — | US | claimed |
| EP-4121279-A1 | METHOD FOR PRODUCING EMBEDDED OR HYBRID HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2023-01-25 | — | — | EP | claimed |
| WO-2021186380-A1 | METHOD FOR PRODUCING EMBEDDED OR HYBRID HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2021-09-23 | — | — | WO | claimed |
| US-20210291469-A1 | METHOD FOR PRODUCING EMBEDDED OR HYBRID HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2021-09-23 | — | — | US | claimed |
| EP-3634732-B1 | METHOD FOR PRODUCING SILICONE HYDROGEL CONTACT LENSES | ALCON RES LTD (US) | 2021-07-21 | — | — | EP | claimed |
| US-20170166673-A1 | HYDROPHILIZED POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF | ALCON INC. (CH) | 2017-06-15 | — | — | US | claimed |
| WO-2016055814-A1 | GEL FUEL | AIR GLOBAL LIMITED (GB) | 2016-04-14 | — | — | WO | claimed |
| US-8748038-B2 | Cathode active material, cathode including the cathode active material, lithium battery including the cathode, and method of preparing the cathode active material | SAMSUNG SDI CO., LTD. (KR) | 2014-06-10 | — | — | US | claimed |
| US-20130302392-A1 | HYDROGEL MICROCAPSULES | HERCULES LLC | 2013-11-14 | — | — | US | claimed |
| EP-2646002-A2 | HYDROGEL MICROCAPSULES | Isp Investments Inc. (US) | 2013-10-09 | — | — | EP | claimed |
| WO-2013142969-A1 | URETHANES AND UREAS AND PROCESSES | GAO JIAN PING (CA) | 2013-10-03 | — | — | WO | claimed |
| WO-2012075293-A2 | HYDROGEL MICROCAPSULES | ISP INVESTMENTS INC. (US) | 2012-06-07 | — | — | WO | claimed |
| EP-2367618-A1 | MICROSPHERES | Akzo Nobel N.V. (NL) | 2011-09-28 | — | — | EP | claimed |
| US-20110151325-A1 | Cathode active material, cathode including the cathode active material, lithium battery including the cathode, and method of preparing the cathode active material | SAMSUNG SDI CO., LTD. (KR) | 2011-06-23 | — | — | US | claimed |
| WO-2010072663-A1 | MICROSPHERES | AKZO NOBEL N.V. (NL) | 2010-07-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11717471-B2 | Hydrogel microcapsules | MITF, DSG1, SHH | TDP1 1869/4885TGFBR1 4642/4885FFAR3 3484/4885 |
| US-20130302392-A1 | HYDROGEL MICROCAPSULES | MITF, DSG1, SHH | TDP1 1869/4885TGFBR1 4642/4885FFAR3 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.